We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.
BDSI

Delisted

BDSI was delisted on the 22nd of March, 2022.

Back to rankings

70 hedge funds and large institutions have $79.3M invested in BioDelivery Sciences International, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

47% more call options, than puts

Call options by funds: $311K | Put options by funds: $211K

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

13% more funds holding

Funds holding: 62 → 70 (+8)

9% more capital invested

Capital invested by funds: $73M → $79.3M (+$6.3M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
70
Holders Change
+8
Holders Change %
+12.9%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
22
Reduced
16
Closed
4
Calls
$311K
Puts
$211K
Net Calls
+$100K
Net Calls Change
-$39K

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$6.83M
2
RA
Royce & Associates
New York
+$1.54M
3
BC
Broadfin Capital
New York
+$617K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$416K
5
Millennium Management
Millennium Management
New York
+$290K

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$2.3M
2
Deutsche Bank
Deutsche Bank
Germany
-$1.16M
3
SCM
Stonepine Capital Management
Oregon
-$613K
4
JGC
J. Goldman & Co
New York
-$398K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$359K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$52K +$6.49K +2,347 +15%
SIC
52
Salem Investment Counselors
North Carolina
$51K – – –
SPC
53
Sigma Planning Corp
Michigan
$43K – – –
Balyasny Asset Management
54
Balyasny Asset Management
Illinois
$43K +$40.6K +14,700 New
Macquarie Group
55
Macquarie Group
Australia
$33K +$31K +11,200 New
PCM
56
Prelude Capital Management
New York
$28K +$26.1K +9,448 New
CPIG
57
Chicago Partners Investment Group
Illinois
$26K – – –
FCMT
58
Founders Capital Management (Texas)
Texas
$18K – – –
CHP
59
Cable Hill Partners
Oregon
$15K +$2.76K +1,000 +25%
LTFS
60
Ladenburg Thalmann Financial Services
Florida
$10K -$8.29K -3,000 -47%
IA
61
IFP Advisors
Florida
$9K -$2.76K -1,000 -25%
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8K +$1.3K +469 +21%
EARNEST Partners
63
EARNEST Partners
Georgia
$8K +$7.74K +2,800 New
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$3K -$865 -313 -22%
AA
65
AlphaMark Advisors
Kentucky
$3K – – –
Citigroup
66
Citigroup
New York
$3K – – –
GWM
67
Geneos Wealth Management
Colorado
$2K – – –
FMA
68
FNY Managed Accounts
New York
$1K -$7.46K -2,700 -84%
US Bancorp
69
US Bancorp
Minnesota
$1K – – –
EI
70
EAM Investors
California
– -$2.3M -780,635 Closed
JGC
71
J. Goldman & Co
New York
– -$398K -135,000 Closed
SIM
72
Sterling Investment Management
Arizona
– -$148K -50,000 Closed
T. Rowe Price Associates
73
T. Rowe Price Associates
Maryland
– -$93K -31,500 Closed
Bank of America
74
Bank of America
North Carolina
– -$5.5K -1,990 -94%
1 2
3

BDSI Hedge Fund Activity: Q4 2017 in Review

70 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2017, worth a combined $79.3M — up 8.6% from $73M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BDSI positions and 4 closed out — a net gain of 8 holders — while 22 added to existing stakes and 16 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $6.83M. The largest seller was EAM Investors, exiting entirely with an estimated $2.3M sold.

  • 70 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2017, up from 62 in Q3 2017.
  • Funds reported $79.3M of BioDelivery Sciences International, Inc. stock for Q4 2017, up 8.6% quarter-over-quarter.
  • 12 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2017 and 4 closed out, a net change of +8 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q4 2017 was Avoro Capital Advisors, an estimated $6.83M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q4 2017 was EAM Investors, an estimated $2.3M sold.

Based on aggregated 13F filings for Q4 2017.